Mouse Mtarc2 Conditional Knockout Project (CRISPR/Cas9)

Total Page:16

File Type:pdf, Size:1020Kb

Mouse Mtarc2 Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Mtarc2 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Mtarc2 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Mtarc2 gene (NCBI Reference Sequence: NM_133684.3 ; Ensembl: ENSMUSG00000073481 ) is located on Mouse chromosome 1. 8 exons are identified, with the ATG start codon in exon 1 and the TAG stop codon in exon 7 (Transcript: ENSMUST00000068725). Exon 3 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Mtarc2 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-221J17 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 3 starts from about 44.08% of the coding region. The knockout of Exon 3 will result in frameshift of the gene. The size of intron 2 for 5'-loxP site insertion: 7225 bp, and the size of intron 3 for 3'-loxP site insertion: 1143 bp. The size of effective cKO region: ~669 bp. The cKO region does not have any other known gene. Page 1 of 8 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele gRNA region 5' gRNA region 3' 1 3 4 8 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Mtarc2 Homology arm cKO region loxP site Page 2 of 8 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. Tandem repeats are found in the dot plot matrix. It may be difficult to construct this targeting vector. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(7169bp) | A(27.81% 1994) | C(21.34% 1530) | T(25.39% 1820) | G(25.46% 1825) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 8 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr1 - 184834279 184837278 3000 browser details YourSeq 140 1204 1385 3000 96.8% chr11 - 48791899 48792081 183 browser details YourSeq 135 2421 2591 3000 97.9% chr16 - 5442155 5442347 193 browser details YourSeq 135 1220 1372 3000 96.6% chr15 - 81935816 81935977 162 browser details YourSeq 129 1224 1364 3000 96.5% chr3 + 153699396 153699545 150 browser details YourSeq 129 1221 1371 3000 95.2% chr10 + 91113455 91113610 156 browser details YourSeq 128 95 345 3000 90.7% chr9 + 115389569 115389817 249 browser details YourSeq 127 1229 1377 3000 93.8% chr6 + 120680808 120680960 153 browser details YourSeq 126 1224 1375 3000 93.9% chr16 - 83031185 83031356 172 browser details YourSeq 126 1229 1377 3000 93.9% chr5 + 49080269 49080435 167 browser details YourSeq 126 1216 1352 3000 97.1% chr2 + 53466170 53466317 148 browser details YourSeq 126 1220 1377 3000 94.5% chr13 + 6228772 6228933 162 browser details YourSeq 120 1220 1364 3000 93.6% chr5 + 60036065 60036356 292 browser details YourSeq 118 1218 1360 3000 92.8% chr4 - 86784631 86785016 386 browser details YourSeq 118 1222 1378 3000 92.8% chr11 - 107518351 107518516 166 browser details YourSeq 118 1220 1364 3000 94.8% chr6 + 30371067 30371215 149 browser details YourSeq 115 1220 1364 3000 90.8% chr19 - 4224467 4224676 210 browser details YourSeq 115 1229 1351 3000 97.6% chr11 + 79986694 79986826 133 browser details YourSeq 113 99 493 3000 79.6% chr19 + 22566050 22566263 214 browser details YourSeq 112 1228 1368 3000 91.9% chr1 - 105524495 105524643 149 Note: The 3000 bp section upstream of Exon 3 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr1 - 184830610 184833609 3000 browser details YourSeq 137 1856 2052 3000 84.8% chr14 + 16323963 16324158 196 browser details YourSeq 132 1863 2048 3000 84.4% chr4 + 131754799 131754983 185 browser details YourSeq 127 1880 2050 3000 85.1% chr2 + 24089876 24090043 168 browser details YourSeq 126 1863 2048 3000 82.1% chr18 - 38985221 38985404 184 browser details YourSeq 124 1852 2049 3000 87.9% chr2 - 116942820 116943048 229 browser details YourSeq 123 1866 2040 3000 83.1% chr5 - 120966632 120966803 172 browser details YourSeq 123 1856 2050 3000 85.0% chr5 - 74848351 74848544 194 browser details YourSeq 123 1858 2048 3000 86.8% chr12 - 102955290 102955478 189 browser details YourSeq 119 1883 2046 3000 86.6% chr2 - 153695045 153818356 123312 browser details YourSeq 119 1858 2050 3000 82.3% chr15 + 27102768 27102962 195 browser details YourSeq 118 1856 2050 3000 88.8% chrX - 159081004 159081198 195 browser details YourSeq 117 1866 2046 3000 82.9% chr3 - 87524187 87524363 177 browser details YourSeq 117 1866 2047 3000 81.6% chr7 + 3469826 3470006 181 browser details YourSeq 117 1877 2037 3000 87.2% chr4 + 86372733 86372895 163 browser details YourSeq 116 1863 2040 3000 85.2% chr6 + 114658766 114658941 176 browser details YourSeq 114 1854 2046 3000 87.1% chr9 - 68574125 68574350 226 browser details YourSeq 113 1856 2037 3000 87.1% chr17 - 85081466 85081649 184 browser details YourSeq 113 1863 2046 3000 88.7% chr14 + 20470902 20471084 183 browser details YourSeq 112 1897 2050 3000 84.3% chr8 - 118808672 118808823 152 Note: The 3000 bp section downstream of Exon 3 is BLAT searched against the genome. No significant similarity is found. Page 4 of 8 https://www.alphaknockout.com Gene and protein information: Mtarc2 mitochondrial amidoxime reducing component 2 [ Mus musculus (house mouse) ] Gene ID: 67247, updated on 26-Jun-2020 Gene summary Official Symbol Mtarc2 provided by MGI Official Full Name mitochondrial amidoxime reducing component 2 provided by MGI Primary source MGI:MGI:1914497 See related Ensembl:ENSMUSG00000073481 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as Marc2; Mosc2; mARC1; 2810484M10Rik Expression Broad expression in duodenum adult (RPKM 313.8), small intestine adult (RPKM 139.6) and 19 other tissues See more Orthologs human all Genomic context Location: 1; 1 H5 See Mtarc2 in Genome Data Viewer Exon count: 9 Annotation release Status Assembly Chr Location 108.20200622 current GRCm38.p6 (GCF_000001635.26) 1 NC_000067.6 (184813066..184846451, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 1 NC_000067.5 (186636947..186669726, complement) Chromosome 1 - NC_000067.6 Page 5 of 8 https://www.alphaknockout.com Transcript information: This gene has 10 transcripts Gene: Mtarc2 ENSMUSG00000073481 Description mitochondrial amidoxime reducing component 2 [Source:MGI Symbol;Acc:MGI:1914497] Gene Synonyms 2810484M10Rik, Marc2, Mosc2 Location Chromosome 1: 184,813,068-184,846,451 reverse strand. GRCm38:CM000994.2 About this gene This gene has 10 transcripts (splice variants), 229 orthologues, 2 paralogues, is a member of 1 Ensembl protein family and is associated with 4 phenotypes. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Mtarc2-201 ENSMUST00000068725.9 1917 338aa ENSMUSP00000066715.3 Protein coding CCDS15594 Q922Q1 TSL:1 GENCODE basic APPRIS P1 Mtarc2-207 ENSMUST00000161821.3 687 190aa ENSMUSP00000125374.1 Protein coding - E0CZH6 CDS 3' incomplete TSL:3 Mtarc2-202 ENSMUST00000159293.7 931 No protein - Processed transcript - - TSL:3 Mtarc2-209 ENSMUST00000162501.6 651 No protein - Processed transcript - - TSL:5 Mtarc2-208 ENSMUST00000162261.7 633 No protein - Processed transcript - - TSL:2 Mtarc2-206 ENSMUST00000161359.7 572 No protein - Processed transcript - - TSL:3 Mtarc2-210 ENSMUST00000162866.6 475 No protein - Processed transcript - - TSL:3 Mtarc2-204 ENSMUST00000160982.1 4248 No protein - Retained intron - - TSL:1 Mtarc2-205 ENSMUST00000161341.7 968 No protein - Retained intron - - TSL:2 Mtarc2-203 ENSMUST00000160318.1 433 No protein - Retained intron - - TSL:2 Page 6 of 8 https://www.alphaknockout.com 53.38 kb Forward strand 184.81Mb 184.82Mb 184.83Mb 184.84Mb 184.85Mb Contigs < AC131992.8 Genes (Comprehensive set... < Mtarc1-201protein coding < Mtarc2-201protein coding < Mtarc1-202protein coding < Mtarc2-206processed transcript < Mtarc2-209processed transcript < Mtarc1-203protein coding < Mtarc2-205retained intron < Mtarc2-204retained intron < Mtarc2-208processed transcript < Mtarc2-203retained intron < Mtarc2-207protein coding < Mtarc2-210processed transcript < Mtarc2-202processed transcript < Mir1981-201miRNA Regulatory Build 184.81Mb 184.82Mb 184.83Mb 184.84Mb 184.85Mb Reverse strand 53.38 kb Regulation Legend CTCF Enhancer Open Chromatin Promoter Promoter Flank Gene Legend Protein Coding merged Ensembl/Havana Ensembl protein coding Non-Protein Coding processed transcript RNA gene Page 7 of 8 https://www.alphaknockout.com Transcript: ENSMUST00000068725 < Mtarc2-201protein coding Reverse strand 32.81 kb ENSMUSP00000066... Transmembrane heli... Low complexity (Seg) Superfamily SSF141673 Pyruvate kinase-like, insert domain superfamily Pfam MOSC, N-terminal beta barrel Molybdenum cofactor sulfurase, C-terminal PROSITE profiles Molybdenum cofactor sulfurase, C-terminal PANTHER PTHR14237:SF27 PTHR14237 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant synonymous variant Scale bar 0 40 80 120 160 200 240 280 338 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 8 of 8.
Recommended publications
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • About the Existence of Common Determinants of Gene Expression In
    González-Prendes et al. BMC Genomics (2019) 20:518 https://doi.org/10.1186/s12864-019-5889-5 RESEARCH ARTICLE Open Access About the existence of common determinants of gene expression in the porcine liver and skeletal muscle Rayner González-Prendes1,6†, Emilio Mármol-Sánchez1†, Raquel Quintanilla2, Anna Castelló1,3, Ali Zidi1, Yuliaxis Ramayo-Caldas1, Tainã Figueiredo Cardoso1,4, Arianna Manunza1,ÁngelaCánovas1,5 and Marcel Amills 1,3* Abstract Background: The comparison of expression QTL (eQTL) maps obtained in different tissues is an essential step to understand how gene expression is genetically regulated in a context-dependent manner. In the current work, we have compared the transcriptomic and eQTL profiles of two porcine tissues (skeletal muscle and liver) which typically show highly divergent expression profiles, in 103 Duroc pigs genotyped with the Porcine SNP60 BeadChip (Illumina) and with available microarray-based measurements of hepatic and muscle mRNA levels. Since structural variation could have effects on gene expression, we have also investigated the co-localization of cis-eQTLs with copy number variant regions (CNVR) segregating in this Duroc population. Results: The analysis of differential expresssion revealed the existence of 1204 and 1490 probes that were overexpressed and underexpressed in the gluteus medius muscle when compared to liver, respectively (|fold- change| > 1.5, q-value < 0.05). By performing genome scans in 103 Duroc pigs with available expression and genotypic data, we identified 76 and 28 genome-wide significant cis-eQTLs regulating gene expression in the gluteus medius muscle and liver, respectively. Twelve of these cis-eQTLs were shared by both tissues (i.e.
    [Show full text]
  • Protein-Protein Interactions of Human Mitochondrial Amidoxime-Reducing Component in Mammalian Cells John Thomas
    Duquesne University Duquesne Scholarship Collection Electronic Theses and Dissertations Fall 1-1-2016 Protein-Protein Interactions of Human Mitochondrial Amidoxime-Reducing Component in Mammalian Cells John Thomas Follow this and additional works at: https://dsc.duq.edu/etd Recommended Citation Thomas, J. (2016). Protein-Protein Interactions of Human Mitochondrial Amidoxime-Reducing Component in Mammalian Cells (Doctoral dissertation, Duquesne University). Retrieved from https://dsc.duq.edu/etd/61 This Immediate Access is brought to you for free and open access by Duquesne Scholarship Collection. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of Duquesne Scholarship Collection. For more information, please contact [email protected]. PROTEIN-PROTEIN INTERACTIONS OF HUMAN MITOCHONDRIAL AMIDOXIME- REDUCING COMPONENT IN MAMMALIAN CELLS A Dissertation Submitted to the Bayer School of Natural and Environmental Sciences Duquesne University In partial fulfillment of the requirements for the degree of Doctor of Philosophy By John A. Thomas December 2016 Copyright by John A. Thomas October 2016 PROTEIN-PROTEIN INTERACTIONS OF HUMAN MITOCHONDRIAL AMIDOXIME-REDUCING COMPONENT IN MAMMALIAN CELLS By John A. Thomas Approved October 24, 2016 ____________________________________ ____________________________________ Partha Basu, PhD Michael Cascio, PhD Professor of Chemistry and Biochemistry Associate Professor of Chemistry and (Committee Chair) Biochemistry (Committee Member) ____________________________________
    [Show full text]
  • Staphylococcus Epidermidis Rights Reserved; Exclusive Licensee Protects Against Skin Neoplasia American Association for the Advancement 1 1 1 2 2 of Science
    SCIENCE ADVANCES | RESEARCH ARTICLE HEALTH AND MEDICINE Copyright © 2018 The Authors, some A commensal strain of Staphylococcus epidermidis rights reserved; exclusive licensee protects against skin neoplasia American Association for the Advancement 1 1 1 2 2 of Science. No claim to Teruaki Nakatsuji, Tiffany H. Chen, Anna M. Butcher, Lynnie L. Trzoss, Sang-Jip Nam, * original U.S. Government 1 3 3 4 2 1† Karina T. Shirakawa, Wei Zhou, Julia Oh, Michael Otto, William Fenical, Richard L. Gallo Works. Distributed under a Creative We report the discovery that strains of Staphylococcus epidermidis produce 6-N-hydroxyaminopurine (6-HAP), a mol- Commons Attribution ecule that inhibits DNA polymerase activity. In culture, 6-HAP selectively inhibited proliferation of tumor lines but did NonCommercial not inhibit primary keratinocytes. Resistance to 6-HAP was associated with the expression of mitochondrial amidoxime License 4.0 (CC BY-NC). reducing components, enzymes that were not observed in cells sensitive to this compound. Intravenous injection of 6-HAP in mice suppressed the growth of B16F10 melanoma without evidence of systemic toxicity. Colonization of mice with an S. epidermidis strain producing 6-HAP reduced the incidence of ultraviolet-induced tumors compared to mice colonized by a control strain that did not produce 6-HAP. S. epidermidis strains producing 6-HAP were found in the metagenome from multiple healthy human subjects, suggesting that the microbiome of some individuals may confer protection against skin cancer. These findings show a new role for skin commensal bacteria in host defense. INTRODUCTION (17, 18). More recently, several strains of S. epidermidis, S.
    [Show full text]
  • A Missense Variant in Mitochondrial Amidoxime Reducing Component 1 Gene and Protection Against Liver Disease
    bioRxiv preprint doi: https://doi.org/10.1101/594523; this version posted March 31, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease Connor A. Emdin, DPhil, Mary Haas, PhD, Amit V. Khera, MD, Krishna Aragam, MD, Mark Chaffin, MS, Lan Jiang, MS, Wei-Qi Wei, MD PhD, Qiping Feng, PhD, Juha Karjalainen, PhD, Aki Havulinna, DSc, Tuomo Kiiskinen, MD, Alexander Bick, MD, Diego Ardissino, MD, James G. Wilson, MD, Heribert Schunkert, MD, Ruth McPherson, MD, Hugh Watkins, MD PhD, Roberto Elosua, MD PhD, Matthew J Bown, FRCS, Nilesh J Samani, FRCP, Usman Baber, MD, Jeanette Erdmann, PhD, Namrata Gupta, PhD, John Danesh FRCP DPhil, Danish Saleheen, MBBS PhD, Mark Daly, PhD, Joshua Denny, MD, Stacey Gabriel, PhD, Sekar Kathiresan, MD Corresponding Author: Sekar Kathiresan, MD Center for Genomic Medicine Massachusetts General Hospital 185 Cambridge Street, CPZN 5.830 Boston, MA 02114 Email: [email protected] Phone: 617 643 6120 Author Affiliations 1) Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114 (Emdin, Khera, Aragam, Haas, Bick, Kathiresan) 2) Department of Medicine, Harvard Medical School, Boston, MA 02114 (Khera, Aragam, Haas, Emdin, Kathiresan) 3) Program in Medical and Population Genetics, Broad Institute,
    [Show full text]
  • And Post-Translationally N-Myristoylated Proteomes in Human Cells
    ARTICLE Received 5 Mar 2014 | Accepted 5 Aug 2014 | Published 26 Sep 2014 DOI: 10.1038/ncomms5919 OPEN Global profiling of co- and post-translationally N-myristoylated proteomes in human cells Emmanuelle Thinon1,2,*,w, Remigiusz A. Serwa1,*, Malgorzata Broncel1, James A. Brannigan3, Ute Brassat1,2,w, Megan H. Wright1,4,w, William P. Heal1,w, Anthony J. Wilkinson3, David J. Mann2,4 & Edward W. Tate1,4 Protein N-myristoylation is a ubiquitous co- and post-translational modification that has been implicated in the development and progression of a range of human diseases. Here, we report the global N-myristoylated proteome in human cells determined using quantitative chemical proteomics combined with potent and specific human N-myristoyltransferase (NMT) inhibition. Global quantification of N-myristoylation during normal growth or apoptosis allowed the identification of 4100 N-myristoylated proteins, 495% of which are identified for the first time at endogenous levels. Furthermore, quantitative dose response for inhibition of N-myristoylation is determined for 470 substrates simultaneously across the proteome. Small-molecule inhibition through a conserved substrate-binding pocket is also demonstrated by solving the crystal structures of inhibitor-bound NMT1 and NMT2. The presented data substantially expand the known repertoire of co- and post-translational N-myristoylation in addition to validating tools for the pharmacological inhibition of NMT in living cells. 1 Department of Chemistry, Imperial College London, Exhibition Road, London SW7 2AZ, UK. 2 Department of Life Sciences, Imperial College London, Exhibition Road, London SW7 2AZ, UK. 3 York Structural Biology Laboratory, Department of Chemistry, University of York, York YO10 5DD, UK.
    [Show full text]
  • Global Proteome of Lonp1+/- Mouse Embryonal Fibroblasts Reveals Impact on Respiratory Chain, but No Interdependence Between Eral1 and Mitoribosomes
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 10 July 2019 doi:10.20944/preprints201907.0144.v1 Peer-reviewed version available at Int. J. Mol. Sci. 2019, 20, 4523; doi:10.3390/ijms20184523 Research Article Global proteome of LonP1+/- mouse embryonal fibroblasts reveals impact on respiratory chain, but no interdependence between Eral1 and mitoribosomes Jana Key1, Aneesha Kohli1, Clea Bárcena2, Carlos López-Otín2, Juliana Heidler3, Ilka Wittig3,*, and Georg Auburger1,* 1 Experimental Neurology, Goethe University Medical School, 60590 Frankfurt am Main; 2 Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo, 33006 Oviedo, Spain; 3 Functional Proteomics Group, Goethe-University Hospital, 60590 Frankfurt am Main, Germany * Correspondence: [email protected]; [email protected] Abstract: Research on healthy ageing shows that lifespan reductions are often caused by mitochondrial dysfunction. Thus, it is very interesting that the deletion of mitochondrial matrix peptidase LonP1 was observed to abolish embryogenesis, while deletion of the mitochondrial matrix peptidase ClpP prolonged survival. To unveil the targets of each enzyme, we documented the global proteome of LonP1+/- mouse embryonal fibroblasts (MEF), for comparison with ClpP-/- depletion. Proteomic profiles of LonP1+/- MEF generated by label-free mass spectrometry were further processed with the STRING webserver Heidelberg for protein interactions. ClpP was previously reported to degrade Eral1 as a chaperone involved in mitoribosome assembly, so ClpP deficiency triggers accumulation of mitoribosomal subunits and inefficient translation. LonP1+/- MEF also showed Eral1 accumulation, but no systematic effect on mitoribosomal subunits. In contrast to ClpP-/- profiles, several components of the respiratory complex I membrane arm were accumulated, whereas the upregulation of numerous innate immune defense components was similar.
    [Show full text]
  • Epigenetic Trajectories to Childhood Asthma
    Epigenetic Trajectories to Childhood Asthma Item Type text; Electronic Dissertation Authors DeVries, Avery Publisher The University of Arizona. Rights Copyright © is held by the author. Digital access to this material is made possible by the University Libraries, University of Arizona. Further transmission, reproduction, presentation (such as public display or performance) of protected items is prohibited except with permission of the author. Download date 04/10/2021 09:24:24 Link to Item http://hdl.handle.net/10150/630233 1 EPIGENETIC TRAJECTORIES TO CHILDHOOD ASTHMA by Avery DeVries __________________________ Copyright © Avery DeVries 2018 A Dissertation Submitted to the Faculty of the DEPARTMENT OF CELLULAR AND MOLECULAR MEDICINE In Partial Fulfillment of the Requirements For the Degree of DOCTOR OF PHILOSOPHY In the Graduate College THE UNIVERSITY OF ARIZONA 2018 2 3 STATEMENT BY AUTHOR This dissertation has been submitted in partial fulfillment of the requirements for an advanced degree at the University of Arizona and is deposited in the University Library to be made available to borrowers under rules of the Library. Brief quotations from this dissertation are allowable without special permission, provided that an accurate acknowledgement of the source is made. Requests for permission for extended quotation from or reproduction of this manuscript in whole or in part may be granted by the head of the major department or the Dean of the Graduate College when in his or her judgment the proposed use of the material is in the interests of scholarship. In all other instances, however, permission must be obtained from the author. SIGNED: Avery DeVries 4 ACKNOWLEDGEMENTS I would like to thank my dissertation mentor, Donata Vercelli, for endless support throughout this journey and for always encouraging and challenging me to be a better scientist.
    [Show full text]
  • Analysis of Mammalian Gene Function Through Broad-Based Phenotypic
    ARTICLES Analysis of mammalian gene function through broad-based phenotypic screens across a consortium of mouse clinics The function of the majority of genes in the mouse and human genomes remains unknown. The mouse embryonic stem cell knockout resource provides a basis for the characterization of relationships between genes and phenotypes. The EUMODIC consortium developed and validated robust methodologies for the broad-based phenotyping of knockouts through a pipeline comprising 20 disease-oriented platforms. We developed new statistical methods for pipeline design and data analysis aimed at detecting reproducible phenotypes with high power. We acquired phenotype data from 449 mutant alleles, representing 320 unique genes, of which half had no previous functional annotation. We captured data from over 27,000 mice, finding that 83% of the mutant lines are phenodeviant, with 65% demonstrating pleiotropy. Surprisingly, we found significant differences in phenotype annotation according to zygosity. New phenotypes were uncovered for many genes with previously unknown function, providing a powerful basis for hypothesis generation and further investigation in diverse systems. Phenotypic annotations of knockout mutants have been generated for (EMPReSS) database10 catalogs the standard operating procedures about a third of the genes in the mouse genome1. However, the way in (SOPs) that were developed, including operational details and the which the phenotype is screened is often dependent on the expertise and parameters measured. More recently, a major single-center effort interests of the investigator, and in only a few cases has a broad-based to analyze several hundred knockout lines through a phenotyping assessment of phenotype been undertaken that encompassed the analy- pipeline has illuminated the pleiotropy that can be found and the sis of developmental, biochemical, physiological and organ systems2–4.
    [Show full text]
  • Raav-Based Gene Therapy for Molybdenum Cofactor Deficiency Type B" Has Been Written Independently with No Other Sources and Aids Than Quoted
    rAAV-based gene therapy for molybdenum cofactor deficiency type B Doctoral thesis In partial fulfilment of the requirements for the degree "Doctor rerum naturalium (Dr. rer. nat.)" in the Molecular Medicine Study Program at the Georg-August University Göttingen submitted by Joanna Jakubiczka-Smorag born in Czestochowa, Poland Göttingen, 2015 Members of the Thesis Committee: Supervisor Prof. Dr. rer. nat. Peter Burfeind Institute of Human Genetics, University Medical Centre Göttingen Second member of the Thesis Committee Prof. Dr. rer. nat. Peter Schu Department of Cellular Biochemistry, University Medical Centre Göttingen Third member of the Thesis Committee Prof. Dr. med. Wolfgang Brück Institute of Neuropathology, University Medical Centre Göttingen Date of Disputation: 03.06.2015 AFFIDAVIT Herewith I declare that my doctoral thesis entitled: "rAAV-based gene therapy for molybdenum cofactor deficiency type B" has been written independently with no other sources and aids than quoted. Göttingen, 24.04.2015 ………………………………….. TABLE OF CONTENTS TABLE OF CONTENTS TABLE OF CONTENTS ........................................................................................................................... I LIST OF ABBREVIATIONS .................................................................................................................... VI 1 INTRODUCTION .......................................................................................................................... 1 1.1 Molybdenum cofactor (MoCo) deficiency ...........................................................................
    [Show full text]
  • Brno University of Technology Vysoké Učení Technické V Brně
    BRNO UNIVERSITY OF TECHNOLOGY VYSOKÉ UČENÍ TECHNICKÉ V BRNĚ FACULTY OF ELECTRICAL ENGINEERING AND COMMUNICATION FAKULTA ELEKTROTECHNIKY A KOMUNIKAČNÍCH TECHNOLOGIÍ DEPARTMENT OF BIOMEDICAL ENGINEERING ÚSTAV BIOMEDICÍNSKÉHO INŽENÝRSTVÍ TRANSCRIPTOMIC CHARACTERIZATION USING RNA-SEQ DATA ANALYSIS TRANSKRIPTOMICKÁ CHARAKTERIZACE POMOCÍ ANALÝZY RNA-SEQ DAT DOCTORAL THESIS DIZERTAČNÍ PRÁCE AUTHOR Layal Abo Khayal AUTOR PRÁCE SUPERVISOR prof. Ing. Ivo Provazník, Ph.D. ŠKOLITEL BRNO 2017 ABSTRACT The high-throughputs sequence technologies produce a massive amount of data, that can reveal new genes, identify splice variants, and quantify gene expression genome-wide. However, the volume and the complexity of data from RNA-seq experiments necessitate a scalable, and mathematical analysis based on a robust statistical model. Therefore, it is challenging to design integrated workflow, that incorporates the various analysis procedures. Particularly, the comparative transcriptome analysis is complicated due to several sources of measurement variability and poses numerous statistical challenges. In this research, we performed an integrated transcriptional profiling pipeline, which generates novel reproducible codes to obtain biologically interpretable results. Starting with the annotation of RNA-seq data and quality assessment, we provided a set of codes to serve the quality assessment visualization needed for establishing the RNA-Seq data analysis experiment. Additionally, we performed comprehensive differential gene expression analysis, presenting
    [Show full text]
  • Global Proteome of Lonp1+/- Mouse Embryonal
    International Journal of Molecular Sciences Article − Global Proteome of LonP1+/ Mouse Embryonal Fibroblasts Reveals Impact on Respiratory Chain, but No Interdependence between Eral1 and Mitoribosomes Jana Key 1, Aneesha Kohli 1, Clea Bárcena 2, Carlos López-Otín 2, Juliana Heidler 3, Ilka Wittig 3,* and Georg Auburger 1,* 1 Experimental Neurology, Goethe University Medical School, 60590 Frankfurt am Main, Germany; [email protected] (J.K.); [email protected] (A.K.) 2 Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Instituto Universitario de Oncologia (IUOPA), Universidad de Oviedo, 33006 Oviedo, Spain; [email protected] (C.B.); [email protected] (C.L.-O.) 3 Functional Proteomics Group, Goethe-University Hospital, 60590 Frankfurt am Main, Germany; [email protected] * Correspondence: [email protected] (I.W.); [email protected] (G.A.) Received: 9 July 2019; Accepted: 9 September 2019; Published: 12 September 2019 Abstract: Research on healthy aging shows that lifespan reductions are often caused by mitochondrial dysfunction. Thus, it is very interesting that the deletion of mitochondrial matrix peptidase LonP1 was observed to abolish embryogenesis, while deletion of the mitochondrial matrix peptidase Caseinolytic Mitochondrial Matrix Peptidase Proteolytic Subunit (ClpP) prolonged survival. To unveil the targets +/ of each enzyme, we documented the global proteome of LonP1 − mouse embryonal fibroblasts / +/ (MEF), for comparison with ClpP− − depletion. Proteomic profiles of LonP1 − MEF generated by label-free mass spectrometry were further processed with the STRING (Search tool for the retrieval of interacting genes) webserver Heidelberg for protein interactions. ClpP was previously reported to degrade Eral1 as a chaperone involved in mitoribosome assembly, so ClpP deficiency triggers the +/ accumulation of mitoribosomal subunits and inefficient translation.
    [Show full text]